Xiao, P., Gumber, S., Marzinke, M. A., Date, A. A., Hoang, T., Hanes, J., . . . Villinger, F. (2017). Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection. Antimicrob Agents Chemother.
Chicago Style aipamenaXiao, Peng, et al. "Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection." Antimicrob Agents Chemother 2017.
MLA aipamenaXiao, Peng, et al. "Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection." Antimicrob Agents Chemother 2017.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.